內地就互聯網診療監管細節徵求意見 相關股五連跌 平安好醫生(01833.HK)挫16%尋底
國家衛健委就互聯網診療監管細節向社會徵求意見,中金指內地規範互聯網診療監管,料線上處方藥銷售受影響。相關股今天繼續捱沽,尤其是平安好醫生(01833.HK)五連跌屢尋底,最低見36.6元,創26個月低,現報37.45元,急挫16%,為最傷恆科成份股,成交急增至3,198萬股,已創逾八個月高。
京東健康(06618.HK)及之前發盈警的阿里健康(00241.HK)也五連跌,股價分別低見68元及9.76元,後者創21個月低,現報68.3元及9.81元,續跌3.7%及3.4%,成交分別增至620萬股及4,158萬股。
國家衛生健康委組織起草《互聯網診療監管細則(徵求意見稿)》,向社會公開徵求意見。當中提到,醫療機構電子處方、處方審核記錄、處方點評記錄應當可追溯,並向省級監管平台開放數據接口,並應建立網絡安全、個人信息保護、數據使用管理等制度,並與相關合作方簽訂協議,明確各方權責關係。而互聯網診療的醫療服務收費項目和收費標準應在網上公示,方便患者查詢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.